Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection

Jing Chai, Sujie Zhang, Chong Ma, Qimin Mei, Tao Liu, Jihai Liu, Ye-Cheng Liu, Huadong ZhuVirulence 2025 · DOI

TL;DR

This study identifies key clinical and laboratory markers, including the Charlson Comorbidity Index (CCI) and neutrophil-to-lymphocyte ratio (NLR), that predict poor prognosis and mortality in non-HIV patients with nontuberculous mycobacterial (NTM) infections. These findings are crucial for better risk stratification and guiding treatment strategies for this increasingly prevalent and challenging disease.

What Problem Does This Paper Address?

Nontuberculous mycobacterial (NTM) infections are a growing global health concern, characterized by their difficulty in eradication and the need for prolonged treatment. While the incidence of NTM is rising, particularly pulmonary NTM, understanding the factors that lead to poor outcomes and mortality, especially in non-HIV individuals, remains a critical challenge. Existing knowledge gaps include identifying simple, accessible biomarkers that can predict prognosis and guide clinical decision-making. This paper aims to fill this gap by retrospectively analyzing a cohort of NTM patients to pinpoint risk factors associated with mortality and unfavorable prognoses.

Methods

The researchers conducted a retrospective analysis of electronic medical records from Peking Union Medical College Hospital between January 2013 and December 2022. They identified 147 newly diagnosed non-HIV NTM patients who met specific inclusion criteria. Data collected included demographic information, clinical characteristics, laboratory findings (including routine blood tests and lymphocyte subsets), microbiological tests, treatments, and patient outcomes. Statistical analyses involved univariate and multivariate Cox proportional hazards regression models to identify independent predictors of mortality. Kaplan-Meier survival curves were used to assess the prognostic impact of various factors, and Receiver Operating Characteristic (ROC) curves were employed to determine optimal cut-off values for predictive biomarkers. A nomogram was also developed to visually represent the probability of survival based on these identified risk factors.

Datasets

The study utilized a dataset of 147 newly diagnosed non-HIV patients with NTM disease, whose data was collected from the electronic medical records of Peking Union Medical College Hospital between January 2013 and December 2022. This dataset was derived from an initial screening of 745 patients diagnosed with NTM infection. No new benchmarks were introduced; the study focused on analyzing existing patient data.

Key Insights and Ideas

  • Simple Biomarkers Matter: The study highlights that readily available laboratory markers like the neutrophil-to-lymphocyte ratio (NLR) and neutrophil-to-monocyte-plus-lymphocyte ratio (NMLR) can serve as powerful predictors of mortality in NTM patients. This is significant because these markers are often part of routine blood work, making them accessible for early risk assessment.
  • Comorbidity is a Major Factor: The Charlson Comorbidity Index (CCI), a measure of the burden of comorbid diseases, emerged as a significant independent predictor of poor outcomes. This underscores the importance of considering a patient's overall health status beyond the NTM infection itself.
  • Disseminated Disease is a Red Flag: The finding that disseminated NTM infection is a strong predictor of mortality is critical. This form of the disease, where NTM spreads to multiple organs, is inherently more severe and requires urgent attention.
  • Hematological Diseases are High Risk: Patients with hematological diseases were identified as having a significantly higher risk of mortality, suggesting a need for heightened vigilance and potentially tailored treatment approaches for this subgroup.

Key Results

  • Cumulative Mortality: The 5-year cumulative mortality rate for NTM disease patients in this cohort was 24.49%.
  • Predictive Biomarkers:
    • High Charlson Comorbidity Index (CCI) was an independent predictor of unfavorable outcomes.
  • High neutrophil-to-lymphocyte ratio (NLR) was an independent predictor of unfavorable outcomes.
  • Disseminated infection was a significant predictor of mortality (HR, 2.868; 95% CI, 1.489–5.524; p < 0.001).
  • Hematological disease was an independent predictor of unfavorable outcomes.
  • ROC Analysis:
    • NLR had an Area Under the Curve (AUC) of 0.751 with an optimal cut-off of 9.50 for predicting mortality.
  • NMLR had an AUC of 0.763 with an optimal cut-off of 3.83 for predicting mortality.
  • Species Distribution: Mycobacterium avium complex (MAC) was the most frequent NTM species (55.8%), followed by Mycobacterium abscessus (21.2%).
  • Co-infections: The incidence of Aspergillus and Pseudomonas aeruginosa infection was significantly higher in the NTM pulmonary disease group compared to the disseminated NTM group.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study's retrospective nature means it cannot establish causality definitively.
  • Single-Center Study: Data was collected from a single tertiary hospital, which may limit the generalizability of findings to other populations or healthcare settings. The high proportion of patients with immune disorders might be a characteristic of this specific center.
  • Incomplete Data: Some patients were excluded due to incomplete species identification or lack of follow-up data. Not all patients had complete lymphocyte subset analysis.

Future research directions suggested include:

  • Prospective, Multicenter Studies: Conducting prospective, multicenter randomized controlled trials with larger populations is recommended to further validate these findings and evaluate prognosis more robustly.
  • Genetic Factors: Investigating the role of genetic defects in susceptibility and prognosis could provide deeper insights.
  • Broader Biomarker Analysis: Exploring a wider range of biomarkers and their interactions could refine predictive models.

Summary updated

Abstract

Recently, the incidence and prevalence of NTM have been increasing nationwide in many countries. This study aimed to identify risk factors associated with the prognosis and mortality of non-HIV nontuberculous mycobacterial disease patients. This retrospective study was conducted at Peking Union Medical College Hospital. The electronic medical records in the hospital's database from January 2013 to December 2022 were retrospectively reviewed. Relevant data, including clinical characteristics, laboratory findings, microbiological tests, treatments, and outcomes were collected and subjected to statistical analyses. The search identified 745 patients diagnosed with NTM infection, of whom 147 met the inclusion criteria. NTM pulmonary disease was the most commonly observed (<i>n</i> = 93; 63.3%), followed by disseminated infection (<i>n</i> = 43; 29.3%). The most frequent NTM species was <i>Mycobacterium avium</i> complex (55.8%), followed by <i>Mycobacterium abscessus</i> (21.2%). The incidence of <i>Aspergillus</i> and <i>Pseudomonas aeruginosa</i> infection was significantly higher in the NTM pulmonary disease group than in the disseminated NTM group. Cumulative mortality in the total patients was 24.49% at 5 years. High Charlson Comorbidity Index (CCI), high neutrophil-to-lymphocyte-ratio (NLR), haematological disease, and disseminated infection were identified as independent predictors of unfavourable outcomes. The area under the curve (AUC) values for NLR and neutrophil-to-monocyte-plus-lymphocyte-ratio (NMLR) were 0.751 and 0.763 with optimal cut-off values of 9.50 and 3.83, respectively, for prediction of mortality in patients with NTM disease.
BibTeX
@inproceedings{chai2025clinical,
  author = {Jing Chai and Sujie Zhang and Chong Ma and Qimin Mei and Tao Liu and Jihai Liu and Ye-Cheng Liu and Huadong Zhu},
  title = {{Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection}},
  booktitle = {Virulence},
  year = {2025},
  doi = {10.1080/21505594.2025.2459313},
}
Figure